Immunomodulator
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Immunomodulator, covering 2013-04-26 to 2014-01-06. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of Immunomodulator as an Adjunct Therapy in Pulmonary Tuberculosis (TB) Retreatment Patients [Phase 3]